Vaxart (VXRT) has shared an announcement. Vaxart, Inc. stockholders have given the green light for significant expansions to the company’s equity plans and an increase in authorized shares. This move, ...

VAXART ($VXRT) posted quarterly earnings results on Thursday, March 20th. The company reported earnings of -$0.05 per share, beating estimates of -$0.10 by $0.05. The ...

Oppenheimer initiated coverage on Vaxart Inc. (NASDAQ:VXRT), an American biotechnology company focused on the discovery, development, and commercialization of oral recombinant vaccines. The analyst’s ...

Vaxart (NASDAQ:VXRT) shares rose in post-market trading on Wednesday after the company announced the publication of complete data from a Phase 2 trial for its oral pill norovirus vaccine candidate in ...

Vaxart Inc (NASDAQ:VXRT) shares are trading higher in Monday’s after-hours session after the company provided business and cash runway updates. What Happened: Vaxart, a clinical-stage biotechnology ...

Vaxart, Inc. is a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology (VAAST) oral vaccine ...

Vaxart (NASDAQ:VXRT) just reported results for the first quarter of 2024. Vaxart reported earnings per share of -14 cents. This met the analyst estimate for EPS of -14 cents. The company reported ...